197 related articles for article (PubMed ID: 15632028)
1. 18F-FDG PET for detecting myocardial viability: validation of 3D data acquisition.
Brogsitter C; Grüning T; Weise R; Wielepp P; Lindner O; Körfer R; Burchert W
J Nucl Med; 2005 Jan; 46(1):19-24. PubMed ID: 15632028
[TBL] [Abstract][Full Text] [Related]
2. Validation of QGS and 4D-MSPECT for quantification of left ventricular volumes and ejection fraction from gated 18F-FDG PET: comparison with cardiac MRI.
Schaefer WM; Lipke CS; Nowak B; Kaiser HJ; Reinartz P; Buecker A; Krombach GA; Buell U; Kühl HP
J Nucl Med; 2004 Jan; 45(1):74-9. PubMed ID: 14734676
[TBL] [Abstract][Full Text] [Related]
3. Prediction of functional recovery after revascularization in patients with coronary artery disease and left ventricular dysfunction by gated FDG-PET.
Slart RH; Bax JJ; van Veldhuisen DJ; van der Wall EE; Dierckx RA; de Boer J; Jager PL
J Nucl Cardiol; 2006; 13(2):210-9. PubMed ID: 16580957
[TBL] [Abstract][Full Text] [Related]
4. Comparison of LVEF assessed by 2D echocardiography, gated blood pool SPECT, 99mTc tetrofosmin gated SPECT, and 18F-FDG gated PET with ERNV in patients with CAD and severe LV dysfunction.
Raja S; Mittal BR; Santhosh S; Bhattacharya A; Rohit MK
Nucl Med Commun; 2014 Nov; 35(11):1156-61. PubMed ID: 25144559
[TBL] [Abstract][Full Text] [Related]
5. Validation of an evaluation routine for left ventricular volumes, ejection fraction and wall motion from gated cardiac FDG PET: a comparison with cardiac magnetic resonance imaging.
Schaefer WM; Lipke CS; Nowak B; Kaiser HJ; Buecker A; Krombach GA; Buell U; Kühl HP
Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):545-53. PubMed ID: 12589480
[TBL] [Abstract][Full Text] [Related]
6. Phase analysis by gated F-18 FDG PET/CT for left ventricular dyssynchrony assessment: a comparison with gated Tc-99m sestamibi SPECT.
Wang L; Wei HX; Yang MF; Guo J; Wang JF; Fang W; Wang YT
Ann Nucl Med; 2013 May; 27(4):325-34. PubMed ID: 23371445
[TBL] [Abstract][Full Text] [Related]
7. Comparison of 2-dimensional and 3-dimensional acquisition for 18F-FDG PET oncology studies performed on an LSO-based scanner.
Lodge MA; Badawi RD; Gilbert R; Dibos PE; Line BR
J Nucl Med; 2006 Jan; 47(1):23-31. PubMed ID: 16391183
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 99mTc-sestamibi/18FDG DISA SPECT with PET for the detection of viability in patients with coronary artery disease and left ventricular dysfunction.
Slart RH; Bax JJ; de Boer J; Willemsen AT; Mook PH; Oudkerk M; van der Wall EE; van Veldhuisen DJ; Jager PL
Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):972-9. PubMed ID: 15824927
[TBL] [Abstract][Full Text] [Related]
9. A lesion detection observer study comparing 2-dimensional versus fully 3-dimensional whole-body PET imaging protocols.
Lartizien C; Kinahan PE; Comtat C
J Nucl Med; 2004 Apr; 45(4):714-23. PubMed ID: 15073270
[TBL] [Abstract][Full Text] [Related]
10. Comparison of contrast-enhanced MRI with (18)F-FDG PET/201Tl SPECT in dysfunctional myocardium: relation to early functional outcome after surgical revascularization in chronic ischemic heart disease.
Wu YW; Tadamura E; Yamamuro M; Kanao S; Marui A; Tanabara K; Komeda M; Togashi K
J Nucl Med; 2007 Jul; 48(7):1096-103. PubMed ID: 17607039
[TBL] [Abstract][Full Text] [Related]
11. Myocardial viability assessment by PET: (82)Rb defect washout does not predict the results of metabolic-perfusion mismatch.
Stankewicz MA; Mansour CS; Eisner RL; Churchwell KB; Williams BR; Sigman SR; Streeter J; Patterson RE
J Nucl Med; 2005 Oct; 46(10):1602-9. PubMed ID: 16204709
[TBL] [Abstract][Full Text] [Related]
12. Myocardial distribution of (18)F-FDG and (99m)Tc-sestamibi on dual-isotope simultaneous acquisition SPET compared with PET.
Matsunari I; Kanayama S; Yoneyama T; Matsudaira M; Nakajima K; Taki J; Nekolla SG; Takekoshi N; Tonami N; Hisada K
Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1357-64. PubMed ID: 12271419
[TBL] [Abstract][Full Text] [Related]
13. Prediction of functional recovery after revascularization in patients with chronic ischaemic left ventricular dysfunction: head-to-head comparison between 99mTc-sestamibi/18F-FDG DISA SPECT and 13N-ammonia/ 18F-FDG PET.
Slart RH; Bax JJ; van Veldhuisen DJ; van der Wall EE; Irwan R; Sluiter WJ; Dierckx RA; de Boer J; Jager PL
Eur J Nucl Med Mol Imaging; 2006 Jun; 33(6):716-23. PubMed ID: 16523309
[TBL] [Abstract][Full Text] [Related]
14. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
[TBL] [Abstract][Full Text] [Related]
15. Quantitative comparison of analytic and iterative reconstruction methods in 2- and 3-dimensional dynamic cardiac 18F-FDG PET.
Lubberink M; Boellaard R; van der Weerdt AP; Visser FC; Lammertsma AA
J Nucl Med; 2004 Dec; 45(12):2008-15. PubMed ID: 15585474
[TBL] [Abstract][Full Text] [Related]
16. Gated cardiac 13N-NH3 PET for assessment of left ventricular volumes, mass, and ejection fraction: comparison with electrocardiography-gated 18F-FDG PET.
Khorsand A; Graf S; Eidherr H; Wadsak W; Kletter K; Sochor H; Schuster E; Porenta G
J Nucl Med; 2005 Dec; 46(12):2009-13. PubMed ID: 16330564
[TBL] [Abstract][Full Text] [Related]
17. Effect of diabetes mellitus on myocardial 18F-FDG SPECT using acipimox for the assessment of myocardial viability.
Schinkel AF; Bax JJ; Valkema R; Elhendy A; van Domburg RT; Vourvouri EC; Bountioukos MA; Krenning EP; Roelandt JR; Poldermans D
J Nucl Med; 2003 Jun; 44(6):877-83. PubMed ID: 12791813
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of 3D acquisition mode for myocardial FDG PET studies using a BGO-based scanner.
van der Weerdt AP; Boellaard R; Visser FC; Lammertsma AA
Eur J Nucl Med Mol Imaging; 2007 Sep; 34(9):1439-46. PubMed ID: 17333179
[TBL] [Abstract][Full Text] [Related]
19. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction.
Vitale GD; deKemp RA; Ruddy TD; Williams K; Beanlands RS
J Nucl Med; 2001 Dec; 42(12):1730-6. PubMed ID: 11752067
[TBL] [Abstract][Full Text] [Related]
20. Assessment of left ventricular myocardial scar in coronary artery disease by a three-dimensional MR imaging technique.
Yin G; Zhao S; Lu M; Ma N; Zuehlsdorff S; Cheng H; Jiang S; Zhao T; Zhang Y; An J; Lv C; He Z
J Magn Reson Imaging; 2013 Jul; 38(1):72-9. PubMed ID: 23225643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
